STOPPINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.133
EU - Europa 1.644
AS - Asia 1.080
AF - Africa 4
SA - Sud America 4
OC - Oceania 3
Totale 4.868
Nazione #
US - Stati Uniti d'America 2.130
CN - Cina 1.067
IE - Irlanda 521
UA - Ucraina 296
FI - Finlandia 242
DE - Germania 162
IT - Italia 120
SE - Svezia 111
GB - Regno Unito 88
FR - Francia 43
BE - Belgio 21
CZ - Repubblica Ceca 15
RU - Federazione Russa 10
IN - India 7
NL - Olanda 4
PL - Polonia 4
CA - Canada 3
IR - Iran 3
MU - Mauritius 3
CL - Cile 2
HR - Croazia 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
TR - Turchia 2
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
GR - Grecia 1
KE - Kenya 1
MY - Malesia 1
Totale 4.868
Città #
Chandler 535
Dublin 521
Jacksonville 360
Nanjing 317
Beijing 158
Ashburn 119
Nanchang 118
Ann Arbor 98
Princeton 94
Shenyang 92
Lawrence 90
Hebei 89
Wilmington 89
Medford 74
Helsinki 70
Changsha 69
Jiaxing 66
Boardman 57
Hangzhou 41
Tianjin 38
Milan 35
Woodbridge 35
New York 32
Pavia 28
Shanghai 26
Brussels 21
Falls Church 21
Verona 21
Norwalk 17
Brno 14
Dearborn 12
Piscataway 11
Auburn Hills 9
Los Angeles 9
Jinan 8
Munich 8
Houston 7
Washington 6
Kunming 5
London 5
Ningbo 5
Taizhou 5
Changchun 4
Padova 4
Paris 4
San Giuliano Milanese 4
Fairfield 3
Guangzhou 3
Hefei 3
Lanzhou 3
Orange 3
Redwood City 3
Tappahannock 3
Berlin 2
Birmingham 2
Borås 2
Brescia 2
Catania 2
Hyderabad 2
Kamien 2
Las Vegas 2
Marsciano 2
Novokuznetsk 2
Polska 2
San Francisco 2
Seattle 2
St Petersburg 2
Toronto 2
Zagreb 2
Zanjan 2
Andover 1
Athens 1
Auckland 1
Bloomfield 1
Campo Largo 1
Des Moines 1
Focsani 1
Groningen 1
Hanover 1
Irvine 1
Kemerovo 1
Kota Kinabalu 1
Leawood 1
Melbourne 1
Moscow 1
Nairobi 1
Narbonne 1
Nürnberg 1
Oklahoma City 1
Pinehaven 1
Pozzuoli 1
Pune 1
Rome 1
Saint Albans 1
Taganrog 1
Trieste 1
Voronezh 1
Winnipeg 1
Wuhan 1
Totale 3.535
Nome #
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 90
STRUCTURE AT 1.44 A RESOLUTION OF AN N-TERMINALLY TRUNCATED FORM OF THE RAT SERUM COMPLEMENT C3d FRAGMENT 87
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 85
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 84
Divergent biding sites in pyruvate kinase I and II from Escherichia coli. 83
Biological activity and pathological implications of misfolded proteins. 80
Primary structure of three peptides at the catalytic and allosteric sites of the fructose 1,6-bisphosphate-activated pyruvate kinase from Escherichia coli 79
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 76
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 75
Purification of bacteriocin AS-48 from an Enterococcus faecium strain and analysis of the gene cluster involved in its production 75
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 74
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 70
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 70
The molecular defect of Albumin Tagliacozzo: 313Lys--->Asn. 68
Reversed-phase high-performance liquid chromatographic separation and partial structural characterization of chloroplast glyceraldehyde-3-p dehydrogenase 68
Fluorescence detection of fibrillar proteins on silicon microstructures 67
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 67
THE PRIMARY STRUCTURE OF PISCINE (ONCORHYNCHUS MYKISS) RETINOL-BINDING PROTEIN AND A COMPARISON WITH THE THREE-DIMENSIONAL STRUCTURE OF MAMMALIAN RETINOL-BINDING PROTEIN 66
MOLECULAR DEFECTS IN GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 66
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 66
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 66
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 64
THE BOVINE PLASMA RETINOL-BINDING PROTEIN. AMINO ACID SEQUENCE, INTERACTION WITH TRANSTHYRETIN, CRYSTALLIZATION AND PRELIMINARY X-RAY DATA 64
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 64
CHLOROPLAST GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (NADP): AMINO ACID SEQUENCE OF THE SUBUNITS FROM ISOENZYME I AND STRUCTURAL RELATIONSHIP WITH ISOENZYME II 64
STRUCTURE OF THE TRIGONAL CRYSTAL FORM OF BOVINE ANNEXIN IV. 63
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 63
STRUCTURAL CHARACTERIZATION OF TWO GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 61
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 61
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 61
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 61
A new proalbumin variant: albumin Jaffna (-1Arg--->Leu) 60
Proteomics of beta2-microglobulin amyloid fibrils. 60
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 60
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 60
High-performance liquid chromatography of complex mixtures of cyanogen bromide-produced peptides from different proteins. 58
Nanobodies against beta2-microglobulin. 58
INTERACTIONS WITH RETINOL AND RETINOIDS OF BOVINE CELLULAR RETINOL-BINDING PROTEIN 57
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 57
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 57
IDENTIFICATION,RETINOID BINDING, AND X-RAY ANALYSIS OF A HUMAN RETINOL-BINDING PROTEIN 56
Solution structure of beta(2)-microglobulin and insights into fibrillogenesis 56
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 56
THE PISCINE PLASMA RETINOL-BINDING PROTEIN. PURIFICATION, PARTIAL AMINO ACID SEQUENCE AND INTERACTION WITH MAMMALIAN TRANSTHYRETIN OF RAINBOW TROUT (ONCORHYNCHUS MYKISS) RETINOL-BINDING PROTEIN 55
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 55
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 55
Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity 54
Bacterial pyruvate kinases have a shorter N-terminal domain 54
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 54
Biochimica Applicata 53
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 53
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 53
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 52
TWO ALLOALBUMINS WITH IDENTICAL ELECTROPHORETIC MOBILITY ARE PRODUCED BYDIFFERENTLY CHARGED AMINO ACID SUBSTITUTIONS 51
Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing. 51
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 51
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 50
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 50
Screening of Fibrillogenesis Inhibitors of β2-microglobulin: Integrated Strategies by Mass Spectrometry, Capillary Electrophoresis and in Silico Simulations 50
structural characterization of the subunits of spinach chloroplast glyceraldehyde-3-phoshate dehydrogenase (NADP). 49
Determining the energy landscape of proteins by a fast isotope exchange NMR approach. 48
Equilibrium unfolding thermodynamics of {beta}2-microglobulin analyzed through native-state H/D exchange. 47
PROTEIN AND DNA SEQUENCE ANALYSIS OF A PRIVATE GENETIC VARIANT: ALBUMIN ORTONOVO (Glu 505--Lys) 47
Rapid proton-detected NMR assignment for proteins with fast magic angle spinning. 46
Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implication 46
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 45
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 45
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide 43
Embryonic stem and haematopoietic progenitor cells resist to Abeta oligomer toxicity and maintain the differentiation potency in culture 43
DETECTION OF FRAGMENTS OF BETA2-MICROGLOBULIN IN AMYLOID FIBRILS 43
Nanotechnology drives a paradigm shift on protein misfolding diseases and amyloidosis 42
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile 42
Limited proteolysis of chloroplast glyceraldehyde-3-phoshate dehydrogenase (NADP) from Spinacia oleracea. 41
Screening of fibrillogenesis inhibitors of beta2-microglobulin: integrated strategie by MS, CE and docking Studies 41
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. 41
Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein A-I. 39
The solution structure of human ß2-microglobulin reveals the prodromes of its amyloid transition 39
Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications. 38
Structure, folding dynamics and amyloidogenesis of Asp76Asn β2-microglobulin: roles of shear flow, hydrophobic surfaces and α crystallin. 38
Properties of some variants of human beta 2- microglobulin and amyloidogenesis. 36
Monitoring the interaction between β2-microglobulin and the molecular chaperone αB-crystallin by NMR and mass spectrometry: αB-crystallin dissociates β2-microglobulin oligomers. 36
Folding and fibrillogenesis: clues from beta2-microglobulin. 35
Structure, function and amyloidogenic propensity of apolipoprotein A-I. 35
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease 34
Systemic amyloidosis: lessons from beta2-microglobulin 31
Evidence that amyloidogenic light chains undergo antigen-driven selection 31
Probing the influence of citrate-capped gold nanoparticles on an amyloidogenic protein 30
Reduction of conformational mobility and aggregation in W60G β2-microglobulin: assessment by 15N NMR relaxation. 28
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 28
Proteomics in protein misfolding diseases. 27
Single-shot NMR measurement of protein unfolding landscapes. 23
Totale 4.961
Categoria #
all - tutte 15.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 4 8
2019/20201.277 361 488 5 53 8 58 11 63 4 117 101 8
2020/2021523 68 49 16 52 6 74 5 75 18 78 68 14
2021/2022421 4 4 1 5 10 29 21 26 25 18 67 211
2022/20231.499 164 134 13 120 167 131 0 87 624 12 29 18
2023/2024442 60 110 17 20 52 118 4 26 2 19 14 0
Totale 4.961